The Best And Worst Of Best And Worst Lists
They are eye catching. We all love them. The ubiquitous “best of†lists: best school districts, best presidents, best championship teams, best places to eat. It’s the hook that keeps on hooking.
Considering The Patent Cliff
Earlier this year, Jones Lang LaSalle (JLL) released its 2012 Global Life Sciences Cluster Report. The report covers 35 life sciences clusters around the world, from Greater Boston to Kobe, Japan.
Venture Capital Investment Drops 20 Percent In 2012 For Mass. Biotech Companies
The venture capital numbers are in for 2012. According to PWC’s Money
Tree report, total venture capital investment was down for the first time in three years.
NIH Funding Cuts Could Devastate Medical Research In Mass.
Here we go again. The House last week approved legislation suspending the debt ceiling for at least four months.
But it’s only a stop-gap measure on the debt ceiling crisis until May 18.
Mass. Biotech Industry Has Decidedly International Flavor
Whatever happened to that quaint little biotechnology industry that began in Massachusetts in the early 1980s?
Biotech Startups Need Low-Cost Lab Space To Develop
“All I need is a lab bench and a cubicle.†It’s a common request from start-up companies looking for initial lab space so they can begin moving scientific concepts forward. But in a marketplace that includes more than 18 million square feet of commercial laboratory space, finding just 500 or 1,000 square feet for a start-up lab can be a difficult task.
Massachusetts Finds Room For BioPharma
There are few better measures of the health of the Massachusetts biotechnology-pharmaceutical industry than the number of laboratory construction projects in the area.
Region Emerges At Forefront Of Growing Global Industry
By the 1990s, Cambridge had become the destination of choice for biotechs.
From Woburn To Worcester, A New Industry Expands
In 1981, the same year Boston Properties completed Five Cambridge Center, two companies, MedChem Products and BioTek, landed in space renovated for their purposes by William “Bill” Cummings in Woburn.
A New Industry Emerges In Cambridge’s Industrial Wasteland
Massachusetts, home to more than 500 biopharmaceutical companies that employ 50,000 people and provide more than $6.5 billion in payroll, is one of a handful of premier biotech locations in the world.
The Massachusetts biotech industry was built in the late 20th Century with true New England grit and determination, and carved out of hardscrabble settings. Looking back, it seemed as unlikely an industry to blossom here as crops were to grow in the rocky Massachusetts soil the Pilgrims farmed in 1620.
